Your Night Prayer

Learn More About Voyage of Life 2 Youth

Today’s Night Prayer is brought to you by  Catholic CompanyA Night PrayerJesus Christ, my God, I adore You and thank You for all the graces You have given me this day. I offer You my sleep and all the moments of this night. I place myself and all my loved ones, wherever they may be, in Your sacred side and under the mantle of Our Blessed Mother. Let Your holy angels stand watch and keep us in peace. Amen.Quote of the Day“Those whose hearts are pure are temples of the Holy Spirit.” -St. Lucy Today’s Meditation…the idea of sacrifice is so deeply rooted in human nature that all peoples and nations, besides serving God with prayers, hymns, almsgiving and works of penance, offered some kind of sacrifice whereby they honored the true God—or the false deities they venerated as such—it was fitting, no, it was even necessary, that Christ should institute in His Church a holy and divine oblation…whereby the faithful should give to God the glory which is His due and express their own subjection to Him. —Good Catholic Digital Content Series, The Holy MassAn excerpt from Recommended ProductsBedtime Blessings for Little Ones  St. Michael Kids Navy and Silver BraceletExamination of ConscienceThe daily examination of conscience is an ancient Catholic practice. It’s very simple, and it’s designed to help us identify our sins and weaknesses so that we can improve and grow stronger in the spiritual life. Basically, it consists in taking a few minutes at the end of the day to prayerfully review our actions in the light of God’s commandments. The Act of Contrition is often said afterwards. The daily examination also serves as an excellent ongoing preparation for regular Confession. Reflect on the victories and losses Actively reflecting on the high and low points of the day can help you live more intentionally and bring a renewed sense of resolve into the following day.Review your actions, words, and thoughts today. Did you actively guard yourself against temptation? Where did sin creep in?In what moments did you practice virtue and moral courage?Were you attuned to the Holy Spirit’s promptings today? Where did you feel His inspiration?Ask Him for the graces necessary to follow His Will more purposefully tomorrow. Act of Contrition O my God, I am heartily sorry for having offended Thee, and I detest all my sins because of Thy just punishments, but most of all because they offend Thee, my God, Who art all good and deserving of all my love. I firmly resolve with the help of Thy grace to sin no more and to avoid the near occasions of sin. Amen. Practice gratitude It is God’s love that has brought you into existence and to this exact moment. Practice looking for His hand in your day. Where did you feel His loving gaze upon you today?What people or moments helped you see God in your life?Thank God for all these moments!Ask Him to help you recognize His blessings and providence tomorrow. Renew your commitment to Christ Remember our Faith is founded upon a Person—Christ! Renew your personal love and devotion to Him.Thank God for the gift of His Son Jesus and our call to be His disciples.Tell the Lord of your desire to know Christ more personally.If possible, set an intention for your day tomorrow. Ask Our Lord to guide you in this act.Pray a Hail Mary, Our Father, or another beloved prayer.Rest with GodHe determines the number of the stars, He gives to all of them their names. — Psalm 147:4ComplineRead Now Want to reach 2.6 million Catholics?  Click here  to consider sponsoring future Night Prayers!

View this email in your browserPlease add NightPrayer@goodcatholic.com to your address book or list of approved senders.Unsubscribe | Privacy Policy | Contact UsA service of the Network The Catholic Company 615 E. Westinghouse Blvd. Charlotte, North Carolina 28273 1-866-522-8465© 2025 Trinity Road, LLC. All rights reserved.

2025 Reagan National Defense Survey

On this episode of Reaganism, Roger sits down with Rachel Hoff and Thomas Kenna to discuss the findings from the 2025 Reagan National Defense Survey. The discussion highlights the American public’s views on national defense, foreign policy, and international alliances, with a particular focus on the increasing support for NATO and military aid to Ukraine. Rachel and Thomas provide insights into the survey’s methodology and the significance of bipartisan support for American leadership on the global stage. They also explore the public’s perception of threats from China and Russia, and the importance of US military strength in maintaining peace. The conversation concludes with reflections on the evolving geopolitical landscape and the enduring relevance of Reagan’s principles in contemporary policy discussions.https://reaganism.podbean.com/e/interpreting-the-2025-reagan-national-defense-survey/

50+ Years of Nailing Market Shifts Leads to One…

50+ Years of Nailing Market Shifts Leads to One Big WarningVIEW IN BROWSERBY MICHAEL SALVATORE, EDITOR, TRADESMITH DAILYStocks feel, in some ways, like they’re on the edge of a cliff. And this past week, I had the pleasure of talking with someone whose level of experience is rare and invaluable to have at a time like that.His name is Marc Chaikin, and he’s been analyzing and trading markets for more than 50 years. His career stretches all the way back to Wall Street in 1966, where he cut a path that few traders dared to tread into the world of technical analysis.He went on to manage money for legends like Paul Tudor Jones, George Soros, and Steve Cohen… and built technical indicators that have shaped for decades how professional traders analyze the markets.But what struck me most in our conversation wasn’t Marc’s résumé – it was his perspective.Marc has watched markets evolve from chalkboards and ticker tape… to phone orders… to the internet… and today’s hyper-fast, algorithm-driven environment.Recommended Link“Like Buying Amazon in 2005…”Futurist Eric Fry has already led his readers to big gains on Amazon stock. But now he says, it’s time to kick that name to the curb and replace it with a company that’s more like “buying Amazon in 2005.” In his presentation, Eric shows why this company could become 700% more profitable in under 2 years. He reveals the name, ticker and full analysis – completely free right here. Yet through all that change, he believes one thing is exactly the same today as it was in 1966:Most investors still don’t know when the market is quietly shifting beneath their feet. And Marc’s data and analytics tell him that a shift is coming.In his words — “The character of the market could change in a way most people aren’t prepared for.”We’ve partnered with Marc on a special project to give investors like you an early-warning signal BEFORE it happens.He and our CEO Keith Kaplan will reveal more about this Tuesday, 10 am ET, in the Tipping Point 2026 summit.But in the meantime, for this exclusive interview, I asked Marc about the lessons of his days on Wall Street… the origins of the indicators he built… how he called the major twists of the last few years… and why he’s joining forces with TradeSmith right now.It’s one of the most fascinating interviews I’ve done all year. Click the thumbnail below to check it out.If you found Marc’s perspective helpful, you cannot miss what he’s sharing in the Tipping Point 2026 event with our CEO, Keith Kaplan.There, the two will unveil a brand-new piece of technology we’ve built specifically for the fast, whiplash selloffs we expect to see in early 2026.They’ll also reveal the #1 stock to BUY before January 1 and the #1 stock to SELL – confirmed across both TradeSmith’s new indicator and Marc’s famed Power Gauge for self-directed investors.Plus, when you sign up, you’ll get instant access to our Flash Crash Screener. With it, you can see whether any stock you own is set up for a perilous crash or a strong uptrend – down do the day the signal fired.Get all the details about registration for the Tipping Point 2026 event, and access to the free screener, right here.To building wealth beyond measure,Michael Salvatore Editor, TradeSmith Daily

This editorial email containing advertisements was sent to pahovis@aol.com because you are subscribed to this service. To unsubscribe or change your email preferences, please click here. To contact Customer Service, call toll free: 866-385-2076, Mon–Fri, 9am–5pm ET, or email support@tradesmith.com. © 2025 TradeSmith, LLC. All Rights Reserved. 1125 N. Charles Street, Baltimore, MD 21201 Terms of Use  |  Privacy Policy  |  Unsubscribe

Readers’ Favorite RVs of the Year

The Wildsam Photo Contest captured the beauty and fun of the American road.Read more >A dreamy day of apple picking, town browsing and riverbank relaxation.Read more >Explore all the steps to protect your RV from winter’s chill.Read more >Take a photo journey down Rocky Mountain roads.Read more >This year’s list of winners is made up of iconic brands and newcomers to the RV space. Read more >Loop the big lake with a beloved clothing brand.Read more >Hailey Whitters takes her rising star on the road.Read more >A guide to the fine art of towing a toad.Read more >Thios Athens treasure inspired a vintage rock album.Read more >Follow our social! This may be considered an advertising or promotional message from Wildsam Magazine, 2 Marriott Drive, Lincolnshire, IL 60069 Privacy Policy  |  View Web Version To unsubscribe from our email program or update your email preferences, click unsubscribe. © 2025 Good Sam Enterprises, LLC. All rights reserved. WMN027951_12132025  |  WMN_12132025

Strange Crystal Metal Outperforms Silicon Up to 100X

Strange Crystal Metal Outperforms Silicon Up to 100XDear Reader,After almost 70 years, Silicon is at the end of the road.As the BBC reports, “we’ve now squeezed as much as we can from silicon chips.”However, a new element is about to take over.It’s a metal that forms in strange hexagonal crystals.And its performance against silicon is out of this world.This metal is up to 40% more energy-efficient.It processes at speeds up to 20X faster than silicon.And performance is up to 100X better!The Center for Strategic & International Studies reports this new material “has emerged as a frontrunner in the quest to push the boundaries of electronics, ushering in a new era of energy-efficient and high-performance devices.”Now, here’s where it gets exciting.One tiny company owns 250 patents on this technology.And nearly every major tech company is aggressively partnering with them.Samsung, LG, Lenovo, Dell, Xiamo…And the biggest of all, Nvidia.If Nvidia wants faster and more powerful chips, they need this technology.Which is why they are now directly working with this company to use its tech to build state of the art AI super-factories.The reality is… this one company could hold the keys to the entire future of AI and advanced microchips.By this time next, year it might be the most important company in the world.We’ve put together a full presentation on this company and its amazing new crystal metal.If you’re looking for a company that has the same upside as a young Nvidia – which rose 35,600% over the past 10 years – this is it.Watch the Full Presentation Right HereYours in smart speculation,Ryan Fitzwater, CEO Monument Traders AllianceMonument Traders Alliance, LLC You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. Trade of the Day Wake-Up Watchlist is published by Monument Traders Alliance, LLC. To stop receiving special invitations and offers from Trade of the Day Wake-Up Watchlist, please click here. Please note: This will not impact the fulfillment of your subscription in any way. Ready to start investing? Click here now. Questions? Check out our FAQs. Trying to reach us? Contact us here. To cancel by mail or for any other subscription issues, write us at: Trade of the Day Wake-Up Watchlist | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day Wake-Up Watchlist.  © 2025 Monument Traders Alliance, LLC All Rights Reserved  Please do not reply to this email as it goes to an unmonitored inbox.Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.

Dr. Oz: Maintain Brain ‘GPS’ With Healthy Diet

Breaking News from Newsmax.com

Maintain Brain ‘GPS’ With Healthy DietBy Dr. Mehmet Oz and Dr. Mike Roizen, MDsOften cited as the worst blunder in the history of college football, Roy “Wrong Way” Riegels picked up a fumble in the 1929 Rose Bowl and ran toward his opponent’s goal line, resulting in a safety.His team, University of California Golden Bears, lost to Georgia Tech 8-7. How could this happen to the All-American team captain? The explanation didn’t come until the 21st century.Special: Worried About Forgetting Things? Try Dr. Blaylock’s Brain Boosters.In 2014, neuroscientist John O’Keefe discovered the brain’s “inner GPS” (and won a Nobel Prize), which is supposed to keep you oriented to your surroundings. This directional guidance system is located in the entorhinal/subicular region at the base of your brain in the hippocampus.Chances are, when Roy banged heads to get the fumble, it confused his inner GPS and turned him around on the gridiron.We want to point you in the right direction, to overall brain health and to protect your inner GPS.There’s a direct correlation between obesity and shrinking of the hippocampus, so do these things to stay on track:Avoid brain-inflamers. Saturated and trans fats, added sugars and syrups, and any grain that isn’t 100 percent whole cause brain inflammation. Give your brain the fuel it needs to think clearly.Enjoy berry goodness. Elderberries, blueberries, and strawberries are packed with the powerful flavonoid quercetin, which reduces inflammation that’s associated with dementia.Go nuts. Walnuts are rich in omega-3s, but all nuts seem to protect the brain’s vascular system.Feel the beet. Their natural nitrates increase blood flow to the brain.More Links:God’s Word Can Mend the Wounds Medicine Can’t. Your FREE Copy Awaits

Crucial Help for Those Over 40 … Renowned Medical Expert Reveals His Top Five Natural Brain Boosters

Do you ever misplace your car keys or glasses?Do you sometimes have problems finding the right word when speaking?Do you tend to forget appointments — or names of people you just met?If so, you’re not alone …Millions of middle-aged and older Americans face these annoying issues, making them more and more concerned about supporting their memory and overall brain health.Should YOU be worried?Well, according to the American Psychological Association, an estimated 1 in 8 Americans over 65 suffers a loss of brain function.And you don’t even need to be in your 60’s to start feeling a bit foggy — or lose a step in mental quickness.A study in the British Medical Journal tracked 5,000 men and 2,000 women ages 45 to 70 over a decade. Their results indicated that cognitive decline starts as early as age 45.But it could be even worse than that …An even more troubling study reported in Neurobiology of Aging concluded that some aspects of age-related cognitive decline begin in healthy adults when they are in their 20’s and 30’s.So you can imagine that a middle-aged or older brain could truly benefit from some support.Fortunately, a renowned brain expert has discovered a helpful solution …A Powerful Natural Way to Support Cognitive Function — Help Your Brain Remain Healthy as You AgeThat brain expert is Dr. Russell Blaylock, a nationally recognized, board-certified M.D. with 26 years of experience in neurosurgery. Not long ago, Dr. Blaylock left a thriving neurosurgery practice to devote his full attention to natural health, particularly nutritional studies and research.And Dr. Blaylock recently uncovered that you CAN stay mentally alert and reduce memory loss as you age — with a combination of daily activity, following a healthy diet, and taking certain nutritional extracts to support brain function.Even with a brain-healthy diet and lifestyle, supplementing with key nutrients can be a vital step to help your brain operate at peak efficiency.And that’s why Dr. Blaylock and his research team formulated the advanced brain and memory formula Cresceo™. This daily dietary supplement can help support brain function by providing vital nutrients not present in sufficient quantities in the foods you eat.Claim Your Trial Bottle of Cresceo Now!Each Cresceo capsule gives you the optimal daily dosage of five key brain nutrients:Ginkgo BilobaBrahmiPhosphatidylserineHuperzine ADMAEHere’s a bit of background on each of them:Brain Booster #1: Ginkgo BilobaCresceo gives you 300 mg of ginkgo biloba extract daily. Did you realize that ginkgo trees are one of the longest living tree species on the planet? They can live as long as a thousand years.Ginkgo promotes healthy brain function in several important ways.For instance, ginkgo helps increase circulation in the brain and supports cells in the hippocampus.Ginkgo extract also helps enhance energy production by the brain’s mitochondria. This is essential for memory and for helping protect against excitotoxicity (overstimulation of nervous system cells). As we age, a certain enzyme called MAO-B increases in our brain and contributes to age-related cognitive impairment. Ginkgo helps inhibit this enzyme.Although ginkgo biloba has been widely studied, the mechanism by which it supports cognitive function is uncertain. Some researchers believe ginkgo works because it increases blood circulation, while others note that it helps support the synapses or nerve connections in our brain.Brain Booster #2: BrahmiBrahmi is another plant renowned for its power to keep the mind sharp and the memory strong. Dr. Blaylock’s formula gives you 300 mg of brahmi daily — the optimal dosage suggested by research. The brahmi herb, which is also called Bacopa monnieri, is a hardy plant often used in Ayurvedic healing.So how does brahmi support cognitive health?In a double-blind, placebo-controlled trial, published in Psychopharmacology, subjects taking brahmi had significantly improved speed of visual information processing, learning rate, and memory after three months. The researchers concluded that brahmi may improve higher order cognitive processes such as learning and memory.In another double-blind, randomized, placebo-controlled study of the effects of brahmi on cognition, results showed that brahmi improved recall of unrelated word pairs after a short interval. But mainly, in plain terms, brahmi was found to prevent subjects from forgetting what they had recently learned.Brain Booster #3: Phosphatidylserine (PS)Dr. Blaylock’s third brain booster is a bioactive compound with a big name: Phosphatidylserine (or PS).Scientific literature suggests PS may help support memory and cognition. Experimental studies indicate that phosphatidylserine may help restore receptors on brain cells. These receptors permit neurotransmitters to communicate with neurons. For instance, a study published in the journal Nutrition found that, for older adults with moderate age-related cognitive impairment, phosphatidylserine produced consistent modest increases in recall of word lists.A study published in Neurology found that patients treated with PS improved their performance on tests related to learning and memory tasks of daily life. The researchers concluded that phosphatidylserine may be a promising candidate for treatment of memory loss later in life.Cresceo contains a proprietary form of PS called SerinAid 50P®. Studies indicate that SerinAid 50P® may help reduce age-related cognitive decline by supporting key brain functions, including memory, concentration, learning, recall, and focus. Additionally, it shows promise in reducing cortisol levels, which in turn reduces stress.Brain Booster #4: Huperzine A (HA)Now we come to Dr. Blaylock’s fourth special brain booster: Huperzine A, or HA for short.HA is a dietary supplement derived from the Chinese club moss Huperzia serrata. HA works by improving the levels of neurotransmitters in the brain. Neurotransmitters are chemicals that transmit signals from a neuron to a target cell across a synapse. In addition, huperzine A promotes proper inflammatory response and is a powerful antioxidant as well.In a double-blind, placebo-controlled study published in Acta Pharmacologica Sinica, 50 patients with diminished brain function took HA for eight weeks while a control group of 53 patients took a placebo. About 58% of the patients taking HA showed improvements in memory, cognitive, and behavioral functions. In the placebo group, only 36% of the patients improved.Brain Booster #5: DMAEDMAE (dimethylaminoethanol) is a compound naturally produced in the brain. It is also found in small amounts in seafood, including anchovies and sardines.Scientists believe that DMAE speeds up the brain’s synthesis and turnover of a neurotransmitter known as acetylcholine. This neurotransmitter plays a key role in supporting healthy memory and cognitive functioning.DMAE reportedly has a stabilizing effect on cell membranes. As a precursor to choline and acetylcholine, DMAE supports the building and repair of cell membranes, particularly those in the brain. Cell membrane damage has been proposed as one of the key mechanisms involved with the aging process.Well, we’ve covered a lot of ground here — so what does all of this mean for you?You can probably see by now why Dr. Blaylock is confident in the research behind Cresceo — and the ability of these five hand-picked nutrients to provide you with support for your brain health.In fact, he’s so confident that Cresceo can help keep your mind sharp and agile, he wanted to make sure you had the opportunity to try it immediately as part of a SPECIAL OFFER!Claim Your Trial Bottle of Cresceo Now!If you order directly from this special report, premium nutritional supplement company Medix Select will send you a FREE Trial Bottle of Cresceo, a $39.95 value. You pay only a small $4.95 shipping and handling charge and enroll in a convenient smart ship program. Don’t worry, you can easily cancel at any time if you are not completely satisfied with your results.Click the button at the bottom of the page immediately to get your own Trial Bottle of Cresceo mailed right out to you.And you’ll also get a FREE Special Report from Dr. Blaylock: Nature’s Brain Boosters: Essential Nutrients for Peak Mental Performance. Valued at $20, it’s yours at no cost.In this information-packed report, you’ll discover:How much exercise you should do weekly to keep your mind sharp …A fun activity Harvard says can slow age-related memory loss …The one type of water you should never drink …Mental exercises you can do to improve your cognitive function …More detailed information about nutrients with demonstrated benefits on brain performance and memory …And much more …Today, we’ve learned that the older you get, the more likely you are to suffer from memory loss and mental decline.SEVEN BENEFITS OF CRESCEOSupports brain healthSupports cognitive healthSupports brain circulationSupports memory and retentionProvides antioxidant protectionMay reduce age-related memory declineSupport for stress reduction by promoting a reduction in cortisol levelsDr. Blaylock’s five brain nutrients can help support your memory and help keep your mind sharp as you age. Research performed around the world supports the use of these bioactive compounds for mental health and well-being, so don’t miss out on this generous special offer.And when you can put Cresceo to the test for an entire month with this incredible FREE OFFER, you just can’t go wrong …In fact, Medix Select guarantees your satisfaction. Give Cresceo a try today and see firsthand how it helps to improve your cognitive abilities. Doesn’t your brain deserve all the help you can give it?Click the button below right now to get the trial bottle of Cresceo we’ve reserved for you — plus your FREEbonus special report. Remember, your bottle of Cresceo usually sells for $39.95, but it’s yours FREE along with a bonus report, just pay $4.95 shipping. Claim Your Trial Bottle of Cresceo Now!*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Terms and Conditions Apply. Please call or see our website for complete details. All information presented above is for informational purposes only, and is not specifically applicable to any individual’s medical problem(s), concerns, and/or needs. Readers are advised to consult a health professional about any issue regarding their health and well-being. *Testimonials appearing above are from actual customers who have used our products in some way or another. Testimonials reflect their experience with our product and are not necessarily representative of all those who will use our product. ©2024 Medix Health, LLC. All rights reserved. Medix Select is a registered trademark of Medix Health, LLC.>

This email is never sent unsolicited. You have received this Newsmax email because you subscribed to it or someone forwarded it to you. To opt out, see the links below.Remove your email address from our list or modify your profile. We respect your right to privacy. View our policy. This email was sent by: Newsmax.com 362 N. Haverhill Road West Palm Beach, FL 33415 USA DM893244 0101022vozx6

Wall Street Is Finally Catching Up to My Warning

Eric Fry Editor, Smart MoneyDAILY ISSUEWall Street Is Finally Catching Up to My WarningVIEW IN BROWSERHello, Reader.As the business author Peter Drucker observed, “The only thing we know about the future is that it will be different.”Looking back at the past 12 months proves this to be true. Different, unexpected, unprecedented… you can take your pick of adjectives.With all that’s happened this year – the ongoing trade war, the longest government shutdown in U.S. history, and the AI boom’s continued remarkable (and expensive) advancements – it could be easy to assume many market predictions made at the start of this year would be completely worthless by now.However, one forecast I made this year has continued to be proven right.As I wrote to my Fry’s Investment Report members, I expected “the richly valued Mag 7 stocks to lose some of their luster.”My reasoning was pretty straightforward: Valuations were getting stretched, and the cost of staying ahead in AI was, and still is, getting expensive.And my prediction was echoed this week.Wall Street veteran Ed Yardeni announced on Monday that he’s officially going underweight on the Magnificent Seven: Amazon.com Inc. (AMZN), Apple Inc. (AAPL), Alphabet Inc. (GOOGL), Meta Platforms Inc. ( META), Microsoft Corp. (MSFT), Nvidia Corp. ( NVDA), and Tesla Inc. (TSLA).According to Yardeni, the Mag 7 companies face unique, aggressive competition, and he expects the 493 other companies in the S&P to become more valuable.What’s more, the HSBC’s 2026 predictions of a Mag 7 slowdown and improved earnings growth for the rest of the S&P companies back up what I’ve been repeating…Valuations among the most popular investments are now bordering on the unsustainable.Following my forecast’s success, I’d like to take a look at how some of my other predictions held up, especially as certain trends look like they’ll continue in 2026.Then, I’ll share how you can get a jump on playing my predictions.Let’s jump in…Recommended LinkAI Gains Versus Pink-Slip PainsLate-2025 America is an economy with two heartbeats. One pulsing with stock-market wealth while the other suffocates under credit strain and job anxiety. America isn’t collapsing; it’s diverging. To prepare, it’s time to lighten up on stocks like the three Eric Fry reveals right here. And shift toward these more promising companies. Get Futurist Eric Fry’s top 7 buy and sell trade ideas for the age of “Two Americas” right here at no cost today.Unpacking My 2025 Predictions1. Corporate Profit Margins Will SoarI expected companies to squeeze more profit out of their operations this year, which is exactly what happened.The S&P 500 reported a 12.9% earnings growth in the first quarter of 2025 and 12% in the second quarter. Then in the third quarter, 81% of companies in the index went on to beat earnings expectations – a big jump from the 73% average in 2013.As for 2026, Yardeni also mentioned that he believes “that S&P 500 companies’ collective earnings per share will increase from $268 this year to $310 next year.”This is one prediction that could continue to pan out.2. The Pharma Sector Will Outperform the S&P 500While this one didn’t start to go as planned, the pharma sector has rebounded in the latter half of 2025, proving my prediction rightThe pharma industry, as measured by the iShares U.S. Pharmaceuticals ETF (IHE), spent most of the year down or even through late September. But now it’s up 28% year-to-date, compared to a 17.6% rise in the S&P.We can thank recent advancements in the sector for late-year shift toward bigger gains.Consider Fry’s Investment Report holding Bristol-Myers Squibb Co. (BMY)’s announcement that it would continue its Phase 3 study of Cobenfy’s use as a therapy for Alzheimer’s disease. The trial was initially paused due to irregularities at certain study sites, and it was restarted after consultation and agreement with the U.S. Food and Drug Administration.News like this has us excited about our healthcare holdings in Fry’s Investment Report.3. Select Foreign Markets Will Outperform the S&P 500This one is turning out to be true. For the third time in the past 10 years, it looks like the S&P 500 will end the year broadly underperforming the foreign markets.Currently, the S&P 500 ranks 41 out of the top 60 stock indexes in the world. And the iShares MSCI ex-U.S. ETF (ACWX) – a fund that invests in stocks from countries outside the United States – is up 30% since the start of the year.So, I’m holding onto my strongest foreign stocks, including one that’s currently up 80% in eight months…Investing Amid ChaosI’m talking about one of my international stock recommendations in the Fry’s Investment Report portfolio. It is a global performance luxury and lifestyle brand.It manufactures its products outside of the U.S., but possesses a competitive advantage in the U.S. against all the similar brands paying massive tariffs on the products they manufacture in China or Southeast Asia and export to the U.S.You can learn how to access more details about this stock by clicking here.The dollar has stabilized this year, but the low valuations and the broad growth we’re seeing overseas should keep pushing foreign stocks higher, which I expect to continue as we move into 2026.At Fry’s Investment Report, we’re prepared for the different, the same, and everything in between that the future will bring. In fact, I’m releasing my final Fry’s Investment Report monthly issue of the year in just a few days. You can click here to join us before it’s released – and ensure that you are well prepared for the year ahead.Regards,Eric Fry Editor, Smart Money

Manage your account We hope this timely investment research is valuable to you. As you know the markets move fast and conditions change frequently. So please check the current issue for the most recent advice. Please note that we cannot be liable for any missed bulletins caused by overzealous filters. To ensure that you continue to receive this valuable part of your service please take a moment to add services@exct.investorplace.com to your address book. You can reach us at feedback@investorplace.com or by calling 1-800-219-8592.Too many emails? Click or tap Manage my subscription to unsubscribe from free newsletter emails or Unsubscribe from marketing to stop receiving marketing emails.InvestorPlace Media LLC 1125 N. Charles St, Baltimore, MD 21201Copyright 2025 All rights reserved.

Former Trump Advisor Reveals “Mandatory Payout” Opportunity

Dear Reader, 

A former advisor to President Donald Trump just exposed a little-known legal loophole… 

Brad Thomas has revealed how a special class of companies – bound by 26 U.S. Code § 857 – are legally required to pay out 90% of their profits to shareholders… 

And right now, a specific group of these companies is perfectly positioned to profit from a new decision by President Trump. 

For retirees, Brad believes this could be a godsend. 

Find out how to get in on these “Mandatory Payout” stocks in his latest briefing…

Click here to get the name of his #1 “Mandatory Payout” stock to buy now, FREE.

Regards, 

Van Bryan
Managing Editor, Wide Moat Research

---

Just For You

Tesla Bulls See $500 Ahead—But Bears Warn of a Painful Reversal

Author: Sam Quirke. First Published: 12/11/2025. 

Key Points

• Tesla is up 15% in the past month and more than 100% since April.
• However, analysts remain split, with some urging caution and others calling for additional upside. 
• The chart and broader technical setup both point up heading into 2026.

Shares of Tesla Inc. (NASDAQ: TSLA) closed around $445 on Tuesday, Dec. 9, extending a three-week rally that has seen the stock gain almost 15% from its mid-November low.

It remains one of the most polarizing names in the market—some see it as the defining growth story of the decade, while others view it as a stock priced for perfection.

Executive Order 14330: Trump’s Biggest Yet (Ad)

While President Trump’s official salary is $400,000 per year… his tax returns reveal he’s been collecting up to $250,000 PER MONTH from one hidden source. Until recently, most Americans couldn’t touch the type of investment that makes up this investment. But thanks to Executive Order 14330, that just changed. If you love investing in disruptive new companies…Discover how to invest in the fund Trump uses to collect this income >>

But regardless of which side of the debate investors fall on, one thing is clear: the chart is giving the bulls a firm vote of confidence. After briefly dipping to test its rising trendline last month, Tesla bounced strongly, holding comfortably above $400 and keeping its multi-month uptrend intact. That resilience, combined with firm technical momentum, is a positive signal heading into the final weeks of the year.

Bulls See Tesla as a Long-Term Growth Engine

For starters, analysts in Tesla’s bullish camp remain loud and confident.

The latest support comes from Piper Sandler, which reiterated its Overweight rating and $500 price target this week. That call echoed those from Mizuho, Cowen, and Stifel Nicolaus, who all reaffirmed their Buy ratings in recent weeks with similar price targets.

The common argument centers on the company’s vertical integration, expanding product lineup, and continued progress with Full Self-Driving (FSD) technology. They see Tesla as uniquely positioned to capture the next wave of growth from autonomy and AI integration—including the robotaxi rollout, which could start contributing materially to revenue in the coming year.

There’s also confidence that Tesla’s margin pressures have peaked and that operational leverage will return in 2026. Bulls point to recent delivery data, especially out of China, improved cost discipline, and new product cycles as evidence that the company is far from running out of steam.

At a time when the broader market is re-embracing growth stocks, a high-momentum leader like Tesla tends to do well. If the macro backdrop holds through the holidays, this could be one of the cleaner setups among the mega-cap names heading into Q1.

Bearish Sentiment Focuses on Valuation and Competitive Risks

The skeptics, though, aren’t backing down. In the past few days, Morgan Stanley downgraded the stock to Equal Weight and set a $425 price target. That aligns with similarly cautious stances from Barclays, HSBC, and UBS Group in recent weeks, all of whom view Tesla’s valuation as stretched and the execution bar as very high.

The bear case is straightforward: a price-to-earnings (P/E) ratio near 300 leaves little room for mistakes. The company trades at a multiple well above the rest of the automotive industry, and skeptics argue that despite the AI and FSD promise, most profits still come from selling cars—a cyclical business facing increasing competition.

They also point to Tesla’s uneven global performance. While sales momentum in China appears to be improving, its European business continues to lag, and ongoing price cuts in key markets raise concerns about profitability. For now, however, that caution hasn’t translated into price weakness: every recent dip has found buyers, and last month’s test of support appears to have reaffirmed the floor beneath the stock.

The Chart Tells Its Own Story

From a technical perspective, there’s little doubt the argument favors the bulls. The stock’s bounce off $385 confirmed another higher low in the uptrend that’s been running since April. In other words, the structure remains intact with a sequence of higher highs and higher lows.

Momentum indicators are echoing that strength. The stock’s Relative Strength Index (RSI) has turned back up from neutral territory, signaling renewed buying pressure. At the same time, the Moving Average Convergence Divergence (MACD) saw a bullish crossover at the end of November.

The next key test will be the $460–$470 resistance zone, where the stock has stalled multiple times this year. A breakout above that level would open the door to a run at $500—a target bulls have been eyeing for months and one Tesla could realistically test before long.

Thank you for subscribing to Earnings360, a morning newsletter that summarizes quarterly earnings for public companies that trade on U.S. markets.

This message is a sponsored email from Wide Moat Research, a third-party advertiser of Earnings360 and MarketBeat. 


This ad is sent on behalf of Wide Moat Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Wide Moat Research please click here.


If you have questions or concerns about your subscription, don’t hesitate to contact MarketBeat’s U.S. based support team at contact@marketbeat.com.

If you no longer wish to receive email from Earnings360, you can unsubscribe.

© 2006-2025 MarketBeat Media, LLC. 
345 North Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103-7078. USA..

Today’s Bonus Content: 5 Stocks That Could Double in 2026 (Click to Opt-In)

🌎 Daily CryptoBeat for 12/13/2025

Cryptocurrency news for Movement, Coinbase tokenized stock FTX, Caldera, Convex Finance, MindNetwork FHE Token, Falcon Finance, Empower and more…Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more.  Start Your Free Trial.Unsubscribe.VIEW MY PORTFOLIODECEMBER 13TH, 2025You’ve been overcomplicating this… (ad)Most traders spend all day glued to charts, hoping for a big move — but Graham Lindman says the easiest gains this year have come from a simple pricing quirk that appears in blue-chip options over and over again. By entering select $1-or-less contracts on names like Apple, Nvidia, and Google, he’s shown how small moves in the stock can still deliver fast 100%+ wins — without timing the market or relying on complex setups. Now he’s setting up the next round of these “$1 trades” and revealing exactly how he finds them.   CLICK HERE TO SEE HOW THE $1 TRADE SETUP WORKS AND WHERE THE NEWEST OPPORTUNITIES ARECryptocurrency Market OverviewMarket Cap$2.77 trillion24-Hour Volume81.07 billion1-Hour Price Change-0.01%24-Hour Price Change+0.54%7-Day Price Change+0.39% VIEW PERFORMANCE MAP Quick LinksCryptocurrency ScreenerCryptocurrency NewsMy MarketBeatAccount SettingsBitcoin StocksBlockchain StocksCompare Cryptocurrency StocksMarketBeat All AccessCryptocurrency Prices for Saturday, December 13MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIOTITLEPRICEMARKET CAP24-HOUR VOLUME1-HOUR CHANGE1-DAY CHANGE7-DAY CHANGE    Bitcoin (BTC)$90,082.02$1.80 trillion823.39 million-0.10%-0.09%+0.24%    Ethereum (ETH)$3,105.43$374.81 billion13.85 billion-0.19%+1.61%+1.45%    Tether (USDT)$1.00$186.24 billion57.42 billion+0.00%-0.01%-0.01%    Waifu Token (WAIF)$454.82$126.67 billionN/A+0.45%-2.18%N/A    BNB (BNB)$901.45$124.16 billion1.58 billion+0.35%+2.96%+0.59%    XRP (XRP)$2.03$122.29 billion2.07 billion-0.22%+2.33%-0.47%    Lido Staked ETH (stETH)$3,105.90$27.20 billion19.55 million+0.49%+1.64%+1.56%    Wrapped TRON (WTRX)$0.27$23.78 billion799.98 thousand+0.01%-1.01%-5.58%    Dogecoin (DOGE)$0.14$23.41 billion696.92 million-0.04%+3.48%-0.54%    Bitcoin Cash (BCH)$576.89$11.52 billion219.47 million+0.01%-0.09%-1.30%TOTAL+0.08%+0.86%-0.41% VIEW WATCHLIST The Top 10 AI Stocks You Need to Know (ad)Discover the 10 Best AI Stocks to Buy Now! The AI revolution is reshaping the investment landscape, and knowing where to place your bets is crucial. Our free report reveals the 10 top AI stocks that should be on your radar right now. Don’t miss your chance to get in on these high-potential tech plays.   DOWNLOAD YOUR FREE REPORT TODAY.Cryptocurrency News for Saturday, December 13What The Conditional Approval Means For Ripple’s Bank And XRP DECEMBER 13 AT 11:18 AM | BITCOINISTBrazil’s Largest Asset Manager Recommends Investors Put Up to 3% of their Money in Bitcoin to Hedge Against FX, Market Shocks DECEMBER 13 AT 11:18 AM | COINDESKMSCI Isn’t Wrong to Be Cautious on DATs DECEMBER 13 AT 11:17 AM | COINDESKNFT Project Pudgy Penguins Takes Over Las Vegas Sphere in Holiday Campaign DECEMBER 13 AT 11:17 AM | COINDESKMy controversial crypto forecast for 2025 (Ad) DECEMBER 13  |  CRYPTO 101 MEDIA Bitcoin Mining Revenue Remains Thin — Yet Hashrate Refuses to Blink DECEMBER 13 AT 11:10 AM | BITCOINState of Crypto: Policymakers Dominated Most Influential 2025 DECEMBER 13 AT 10:16 AM | COINDESKBitcoin Bullish Structure Weakens As Inter-Exchange Liquidity Touches Red Zone – Details DECEMBER 13 AT 10:16 AM | NEWSBTCGoogle Trends Data Shows Bitcoin Quietly Holding Its Place as the Year Comes to a Close DECEMBER 13 AT 9:31 AM | BITCOINBank of Japan Set to Hike Rates to 30-Year High, Posing Another Threat to Bitcoin DECEMBER 13 AT 9:09 AM | COINDESKCrypto’s Machine Learning ‘iPhone Moment’ Comes Closer as AI Agents Trade the Market DECEMBER 13 AT 8:05 AM | COINDESKXRP Price Holds Above $2 Again — What’s Next For The Altcoin? DECEMBER 13 AT 8:05 AM | NEWSBTCThey’ve called 8,200%… 4,915%… 3,110% memecoin gains (Ad) DECEMBER 13  |  CRYPTO 101 MEDIA Hyperliquid’s Latest Announcement: Why It Could Be A Game Changer For HYPE Investors DECEMBER 13 AT 8:05 AM | BITCOINISTSqueeze Incoming? Bitcoin’s $90K Compression Set to Pop Wide Open DECEMBER 13 AT 8:05 AM | BITCOINSpot volumes drop 66% in ‘lulls’ that often precede next cycle leg: Bitfinex DECEMBER 13 AT 7:18 AM | COINTELEGRAPHU.S. Market Structure Bill May Slide to January as Talks Continue Over Several Points DECEMBER 13 AT 7:18 AM | COINDESKBitcoin Bearish Signals Are ‘Hard To Ignore’: Analyst Warns Of Drop To April Lows DECEMBER 13 AT 7:18 AM | NEWSBTCStrategy survives first Nasdaq 100 shakeup since entering the index DECEMBER 13 AT 7:18 AM | COINTELEGRAPHOptions vs. Futures: Why Crypto’s Options Market Has 97% Room to Grow DECEMBER 13 AT 6:51 AM | BITCOINPhantom integrates Kalshi prediction markets as crypto wallets expand into event trading DECEMBER 13 AT 6:30 AM | COINJOURNALXRP Price To Reach $27: The Technical Formation That Paints 1,300% Surge DECEMBER 13 AT 6:04 AM | NEWSBTCUK Regulator to Finalize Crypto Rules, Advance Stablecoin Framework in 2026 DECEMBER 13 AT 4:51 AM | BITCOINSolana’s Long-Awaited Firedancer Launch Sparks 5% Rally DECEMBER 13 AT 4:10 AM | NEWSBTCBrazil’s largest private bank advises investors to allocate 3% to Bitcoin in 2026 DECEMBER 13 AT 3:05 AM | COINTELEGRAPHTRM Labs Underscores Venezuela’s Positive Crypto Adoption in a Risky Ecosystem DECEMBER 13 AT 2:50 AM | BITCOINKalshi To Power Coinbase New Internal Prediction Platform, Insider Reveals DECEMBER 13 AT 2:11 AM | NEWSBTCRipple Payments Lands First European Bank With AMINA Bank AG DECEMBER 13 AT 2:10 AM | THEMERKLEJupiter Pushes Onchain Finance Forward With Its Biggest Upgrade Wave Yet DECEMBER 13 AT 2:10 AM | THEMERKLEa16z’s 2026 Crypto Vision: Stablecoins Surge, Tokenization Grows, and Asia Becomes the Next Battleground DECEMBER 13 AT 1:30 AM | THEMERKLEHTX Approved for Pakistan Crypto Exchange Registration DECEMBER 13 AT 1:11 AM | BITCOINCrypto groups slam Citadel for urging tighter DeFi tokenization rules DECEMBER 13 AT 1:10 AM | COINTELEGRAPHXRP Mildly Undervalued On MVRV: What About Bitcoin, Ethereum? DECEMBER 13 AT 1:10 AM | NEWSBTCYoutube Expands Creator Monetization Using Paypal USD Stablecoin DECEMBER 13 AT 12:50 AM | BITCOINCrypto Exchange Binance To Assist Pakistan In Tokenizing $2 Billion In Government Bonds DECEMBER 13 AT 12:30 AM | NEWSBTCBinance And HTX Get Regulatory Nod To Operate In Pakistan – Details DECEMBER 13 AT 12:30 AM | BITCOINISTCFTC Scraps Outdated Crypto Rules, Signals Fresh Momentum Ahead DECEMBER 13 AT 12:10 AM | BITCOINEthereum Trades Near Whales’ Cost Basis For The Fourth Time Since 2021 – Historic Test DECEMBER 12 AT 11:31 PM | NEWSBTCCrypto Unrealized Losses Hit $350 Billion, With $85 Billion From Bitcoin Alone DECEMBER 12 AT 11:31 PM | BITCOINISTRipple Closes Rail Acquisition to offer Most Comprehensive End-to-End Stablecoin Payments Solution DECEMBER 12 AT 10:51 PM | BITCOINNot Just Crypto: Research Says XRP Is Moving Into Bank-Grade Payment Infrastructure DECEMBER 12 AT 10:31 PM | BITCOINISTBitcoin On-Chain Signals Delay Bull Thesis: MVRV Model Projects Recovery Next Cycle DECEMBER 12 AT 10:31 PM | BITCOINISTBinance’s USD1 Stablecoin Push Deepens Relationship With Trump’s Crypto Platform DECEMBER 12 AT 10:31 PM | NEWSBTCHistoric Milestone: Tokenized Securities Move Closer to Wall Street Core as DTCC Gains SEC Clearance DECEMBER 12 AT 9:35 PM | BITCOINXRP Whale Activity Spikes At The Bottom – A Classic Pre-Rally Signal DECEMBER 12 AT 9:33 PM | NEWSBTCSEC Chair Touts Crypto-Led Shift To On-Chain Finance DECEMBER 12 AT 8:37 PM | BITCOINISTHalf-Billion Dollar Bet: Bitcoin OG Scales Multi-Asset Long To $611 Million DECEMBER 12 AT 8:37 PM | BITCOINISTDogecoin Tightens Up: Symmetrical Triangle Converges With High-Timeframe Wyckoff Setup DECEMBER 12 AT 8:37 PM | NEWSBTCStablecoin giant Tether makes $1B bid to buy Juventus FC DECEMBER 12 AT 8:37 PM | COINTELEGRAPHXRP Liquidity Scales Across Chains as wXRP Expands Through Hex Trust DECEMBER 12 AT 8:37 PM | BITCOINCircle, Ripple, Bitgo, Fidelity, and Paxos Conditionally Approved for National Trust Banks DECEMBER 12 AT 7:51 PM | BITCOINSolana Gains Institutional Momentum as New On-Chain Bond Deal and XRP Integration Build Hype DECEMBER 12 AT 7:32 PM | NEWSBTC VIEW ALL NEWS January 1 Bombshell (ad)‘Bigger Than the Internet’ Whitney Tilson just uncovered a phenomenon he believes could be “bigger than the Internet”… With billionaires pouring in and federal agencies clearing the runway, the early phase is ending fast. You still have a narrow chance to prepare – if you act before Jan 1.   TAP HERE TO SEE THE URGENT BRIEFING.Calendars from MarketBeatU.S. Analyst RatingsCongressional BuyingCorporate BuybacksCryptocurrenciesDividend DeclarationsEarnings AnnouncementsEarnings Conference CallsFDA CalendarGap Up/Down StocksInsider TradesInitial Public Offerings (IPOs)Most Active StocksPercentage Gainers/DeclinersSector PerformanceShort InterestStock SplitsUnusual Options VolumeUnusual Trading VolumeGET 30 DAYS OF MARKETBEAT ALL ACCESS FREESign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIALThank you for subscribing to MarketBeat!We empower investors to make better investment decisions by providing real-time financial information and independent market analysis. If you have questions or concerns about your account, feel free to email our South Dakota based support team at contact@marketbeat.com. If you would like to opt out or modify which emails you receive, you may modify your subscription preferences or unsubscribe from these emails. © 2006-2025 MarketBeat Media, LLC.  345 North Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103-7078. United States of America..From Our Partners: Buy Alert (Click to Opt-In)

Mets reinforce infield with deal for Polanco

Saturday, December 13View In Browser   Mets bring in Polanco on two-year deal (reports) Switch-hitting infielder Jorge Polanco, who played October hero during the Mariners’ run to the American League Championship Series, is heading to the Mets on a two-year, $40 million deal, per MLB Network insider Jon Heyman. All the latest buzzWe’re keeping track of all the free-agent and trade rumors all winter long. Every free agent, sorted by positionHere is a position-by-position breakdown of the 2025-26 free-agent class.MLB MORNING LINEUP PODCAST   © 2025 MLB Advanced Media, L.P. MLB trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com. Any other marks used herein are trademarks of their respective owners. Please review our Privacy Policy. You (pahovis@aol.com) received this message because you registered to receive commercial email messages from MLB.com. Please add info@marketing.mlbemail.com to your address book to ensure our messages reach your inbox. If you no longer wish to receive commercial email messages from MLB.com, please unsubscribe  or log in and manage your email subscriptions. Postal Address: MLB.com, c/o MLB Advanced Media, L.P., 1271 Avenue of the Americas, New York, NY 10020.